Trump Unveils New Tariffs on Pharmaceuticals and Metals to Spur US Production
In a significant move to bolster domestic manufacturing, US President Donald Trump has rolled out a new set of tariffs targeting pharmaceuticals and key metals. This announcement comes exactly one year after the so-called "Liberation Day" tariffs, which disrupted global supply chains and financial markets. Although those earlier measures were struck down by the Supreme Court earlier this year, the administration has persisted with similar policies through alternative mechanisms.
Steep Tariffs on Patented Pharmaceuticals
The latest executive order imposes a steep 100% tariff on patented drugs produced outside the United States. This measure is designed to incentivize pharmaceutical companies to relocate their production domestically. Companies can avoid the full tariff by negotiating trade agreements with Washington or committing to establish manufacturing facilities within the US.
Officials have outlined that large pharmaceutical firms have 120 days to submit "reshoring plans," while smaller companies are granted 180 days before the tariff takes effect. Those that commit to building plants, with completion expected by the end of Trump's potential second term, will face a reduced tariff of 20% instead.
A senior US official stated, "We expect the lion's share of the world's patented pharmaceuticals to be building in America." The White House emphasized that this move aims to reduce US dependence on foreign nations for essential medicines, with countries like India specifically mentioned as being affected.
According to an official cited by ANI, "100% tariff is on patented products. Any patented drug imports from India made by companies that do not get approved for a reshoring plan will be subject to a 100% tariff."
Exemptions and Reduced Rates for Some Nations
Not all trading partners face the full brunt of these tariffs. The European Union, Japan, South Korea, and Switzerland have been granted exemptions, facing a 15% tariff under prior agreements. Britain has secured tariff-free access for its medicines for three years as part of a broader deal, according to the US Trade Representative’s office.
Additional relief is available for companies that enter "Most Favored Nation" pricing arrangements with the administration while also investing in US-based manufacturing. Generic medicines are currently excluded from the tariffs, though this policy will be reviewed after one year.
Revised Tariffs on Steel, Aluminium, and Copper
Alongside the pharmaceutical measures, Trump signed a proclamation reshaping tariffs on steel, aluminium, and copper, citing national security concerns and the need to strengthen domestic industry. Under the revised framework, tariffs will be calculated based on the full value of imported products rather than lower foreign price benchmarks.
- Products made almost entirely of these metals will attract a flat 50% tariff.
- Derivative goods containing substantial amounts will face a 25% duty on their full value.
- Certain industrial and electrical grid equipment will be taxed at 15% through 2027.
- Goods produced abroad using entirely American metals will face a lower 10% tariff.
- Items with minimal metal content, 15% or less, will no longer be subject to these duties.
The changes are set to take effect from 12:01 am Eastern Time on Monday.
Administration's Rationale and Impact
A senior administration official explained that the overhaul addresses concerns that "foreign countries were artificially manipulating" prices to reduce tariff payments. The revised structure aims to simplify the system and ensure fairer enforcement, with the official adding, "It’s a simplification and a fairness issue."
Despite concerns about rising costs ahead of midterm elections, the administration maintained that these measures would not affect household expenses. The official insisted, "These will not have impact on the price of the good on the shelf."
The White House stated that these steps are part of a broader push to bolster domestic production of strategic materials and reinforce economic and national security. Officials highlighted ongoing expansion in US metals industries, including new steelmaking capacity and investments in aluminium and copper production, as evidence of the impact of existing tariff policies.
This latest proclamation builds on earlier actions under the Section 232 programme, which has been used to impose and expand tariffs on key industrial imports. According to the administration, these measures have supported domestic producers, encouraged investment, helped create jobs, and ensured that American industries can compete more effectively on the global stage.
